Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022657661> ?p ?o ?g. }
- W2022657661 endingPage "230" @default.
- W2022657661 startingPage "224" @default.
- W2022657661 abstract "Conventional chemotherapy is still frequently used. Programmed cell death 5 (PDCD5) enhances apoptosis of various tumor cells triggered by certain stimuli and is lowly expressed in leukemic cells from chronic myelogenous leukemia patients. Here, we describe for the first time that recombinant human PDCD5 protein (rhPDCD5) in combination with chemotherapy drugs has potent antitumor effects on chronic myelogenous leukemia K562 cells in vitro and in vivo. The antitumor efficacy of rhPDCD5 protein with chemotherapy drugs, idarubicin (IDR) or cytarabine (Ara-C), was examined in K562 cells in vitro and K562 xenograft tumor models in vivo. rhPDCD5 protein markedly increased the apoptosis rates and decreased the colony-forming capability of K562 cells after the combined treatment with IDR or Ara-C. rhPDCD5 protein by intraperitoneal administration dramatically improved the antitumor effects of IDR treatment in the K562 xenograft model. The tumor sizes and cell proliferation were significantly decreased; and TUNEL positive cells were significantly increased in the combined group with rhPDCD5 protein and IDR treatment compared with single IDR treatment groups. rhPDCD5 protein, in combination with IDR, has potent antitumor effects on chronic myelogenous leukemia K562 cells and may be a novel and promising agent for the treatment of chronic myelogenous leukemia." @default.
- W2022657661 created "2016-06-24" @default.
- W2022657661 creator A5018863416 @default.
- W2022657661 creator A5020584779 @default.
- W2022657661 creator A5027220663 @default.
- W2022657661 creator A5033143394 @default.
- W2022657661 creator A5033822228 @default.
- W2022657661 creator A5041638115 @default.
- W2022657661 creator A5051046606 @default.
- W2022657661 creator A5065560361 @default.
- W2022657661 creator A5068260956 @default.
- W2022657661 creator A5080339785 @default.
- W2022657661 date "2010-05-01" @default.
- W2022657661 modified "2023-10-14" @default.
- W2022657661 title "Potent antitumor activities of recombinant human PDCD5 protein in combination with chemotherapy drugs in K562 cells" @default.
- W2022657661 cites W1967405017 @default.
- W2022657661 cites W1994028261 @default.
- W2022657661 cites W2006917576 @default.
- W2022657661 cites W2008233728 @default.
- W2022657661 cites W2028959752 @default.
- W2022657661 cites W2032352097 @default.
- W2022657661 cites W2051345002 @default.
- W2022657661 cites W2054717287 @default.
- W2022657661 cites W2068302866 @default.
- W2022657661 cites W2068646526 @default.
- W2022657661 cites W2069804459 @default.
- W2022657661 cites W2076814039 @default.
- W2022657661 cites W2081306620 @default.
- W2022657661 cites W2082580993 @default.
- W2022657661 cites W2088918684 @default.
- W2022657661 cites W2103205123 @default.
- W2022657661 cites W2119183961 @default.
- W2022657661 cites W2126158899 @default.
- W2022657661 cites W2133610390 @default.
- W2022657661 cites W2171722798 @default.
- W2022657661 doi "https://doi.org/10.1016/j.bbrc.2010.04.068" @default.
- W2022657661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20398626" @default.
- W2022657661 hasPublicationYear "2010" @default.
- W2022657661 type Work @default.
- W2022657661 sameAs 2022657661 @default.
- W2022657661 citedByCount "31" @default.
- W2022657661 countsByYear W20226576612012 @default.
- W2022657661 countsByYear W20226576612013 @default.
- W2022657661 countsByYear W20226576612014 @default.
- W2022657661 countsByYear W20226576612015 @default.
- W2022657661 countsByYear W20226576612016 @default.
- W2022657661 countsByYear W20226576612017 @default.
- W2022657661 countsByYear W20226576612019 @default.
- W2022657661 countsByYear W20226576612020 @default.
- W2022657661 countsByYear W20226576612023 @default.
- W2022657661 crossrefType "journal-article" @default.
- W2022657661 hasAuthorship W2022657661A5018863416 @default.
- W2022657661 hasAuthorship W2022657661A5020584779 @default.
- W2022657661 hasAuthorship W2022657661A5027220663 @default.
- W2022657661 hasAuthorship W2022657661A5033143394 @default.
- W2022657661 hasAuthorship W2022657661A5033822228 @default.
- W2022657661 hasAuthorship W2022657661A5041638115 @default.
- W2022657661 hasAuthorship W2022657661A5051046606 @default.
- W2022657661 hasAuthorship W2022657661A5065560361 @default.
- W2022657661 hasAuthorship W2022657661A5068260956 @default.
- W2022657661 hasAuthorship W2022657661A5080339785 @default.
- W2022657661 hasConcept C126322002 @default.
- W2022657661 hasConcept C150903083 @default.
- W2022657661 hasConcept C171122931 @default.
- W2022657661 hasConcept C185592680 @default.
- W2022657661 hasConcept C190283241 @default.
- W2022657661 hasConcept C202751555 @default.
- W2022657661 hasConcept C203014093 @default.
- W2022657661 hasConcept C207001950 @default.
- W2022657661 hasConcept C2776694085 @default.
- W2022657661 hasConcept C2776960273 @default.
- W2022657661 hasConcept C2778041864 @default.
- W2022657661 hasConcept C2778461978 @default.
- W2022657661 hasConcept C502942594 @default.
- W2022657661 hasConcept C55493867 @default.
- W2022657661 hasConcept C71924100 @default.
- W2022657661 hasConcept C86803240 @default.
- W2022657661 hasConcept C98274493 @default.
- W2022657661 hasConceptScore W2022657661C126322002 @default.
- W2022657661 hasConceptScore W2022657661C150903083 @default.
- W2022657661 hasConceptScore W2022657661C171122931 @default.
- W2022657661 hasConceptScore W2022657661C185592680 @default.
- W2022657661 hasConceptScore W2022657661C190283241 @default.
- W2022657661 hasConceptScore W2022657661C202751555 @default.
- W2022657661 hasConceptScore W2022657661C203014093 @default.
- W2022657661 hasConceptScore W2022657661C207001950 @default.
- W2022657661 hasConceptScore W2022657661C2776694085 @default.
- W2022657661 hasConceptScore W2022657661C2776960273 @default.
- W2022657661 hasConceptScore W2022657661C2778041864 @default.
- W2022657661 hasConceptScore W2022657661C2778461978 @default.
- W2022657661 hasConceptScore W2022657661C502942594 @default.
- W2022657661 hasConceptScore W2022657661C55493867 @default.
- W2022657661 hasConceptScore W2022657661C71924100 @default.
- W2022657661 hasConceptScore W2022657661C86803240 @default.
- W2022657661 hasConceptScore W2022657661C98274493 @default.
- W2022657661 hasFunder F4320321001 @default.
- W2022657661 hasIssue "2" @default.
- W2022657661 hasLocation W20226576611 @default.